Related Experiment Video
Updated: Jun 15, 2026
04:41
Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
Published on: July 14, 2010
Agmatine prevents LPS-induced spatial memory impairment and hippocampal apoptosis
Asadollah Zarifkar1, Samira Choopani, Rasoul Ghasemi
1Neuroscience Research Center and department of Physiology, Shiraz University of Medical sciences, Shiraz, Iran.
European Journal of Pharmacology
|February 27, 2010
Summary
Agmatine, an arginine metabolite, protected against lipopolysaccharide (LPS)-induced spatial memory deficits and hippocampal apoptosis in rats, suggesting neuroprotective potential.
Area of Science:
- Neuroscience
- Pharmacology
- Cell Biology
Background:
- Neuroinflammation is a key factor in neurodegenerative diseases.
- Lipopolysaccharide (LPS) is known to trigger neuroinflammation and impair memory.
- Agmatine, derived from arginine, is a potential neuroprotective compound.
Purpose of the Study:
- To investigate if agmatine can counteract LPS-induced spatial memory impairment.
- To determine agmatine's effect on hippocampal apoptosis following LPS exposure.
Main Methods:
- Adult male Wistar rats were trained using a water maze task.
- Rats received saline, LPS, or LPS with varying doses of agmatine.
- Western blot analysis was used to assess hippocampal caspase-3 activation.
Main Results:
- LPS treatment significantly impaired spatial learning in the water maze.
- Agmatine co-administration prevented LPS-induced memory deterioration.
- LPS exposure increased hippocampal caspase-3 activation, which was inhibited by agmatine.
Conclusions:
- Agmatine demonstrates neuroprotective effects against LPS-induced neuroinflammation and memory loss.
- Agmatine may prevent hippocampal apoptosis by inhibiting caspase-3 activation.
- Agmatine holds promise as a therapeutic agent for neurodegenerative conditions involving neuroinflammation.
